BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2016
View Archived Issues
Efficacy and safety of ribavirin-free DAA treatments in patients with severe renal impairment
Read More
AzurRx BioPharma and Mayoly Spindler launch phase II study of MS-1819-SD
Read More
EC grants orphan drug designation to Ra Pharmaceuticals' RA-101495
Read More
L807-mts demonstrates promising results in mouse model of Alzheimer's disease
Read More
Novel Zika virus infection model in immunocompetent neonatal C57Bl/6 mice
Read More
VH-298 is a novel potent and selective chemical probe of hypoxic signaling
Read More
Novel animal models presented at the Society for Neuroscience annual meeting
Read More
Nippon Boehringer Ingelheim and Astellas launch Micatrio combination tablets in Japan
Read More
PharmAkea extends collaboration with Celgene
Read More
Omeros patents PDE10A inhibitors
Read More
University of North Carolina at Chapel Hill discloses anticancer agents
Read More
Shanghai Fochon Pharmaceutical describes CDK4/cyclin D1 and CDK6/cyclin D1 inhibitors
Read More
Chinese scientists develop Nav1.7 channel blockers
Read More
Laboratorios del Dr. Esteve presents dual sigma1 and mu-opioid receptor ligands
Read More
UMC launches phase II program combining DCVax-L and pembrolizumab
Read More
Alzheimer's Association grant supports Proclara's development of NPT-088
Read More
Athenex to conduct phase Ib study of Oraxol in combination with ramucirumab
Read More
Apricus plans for Vitaros NDA resubmission next year
Read More
Medicure to acquire majority interest in Apicore
Read More
Novartis acquires Selexys Pharmaceuticals
Read More
Aska Pharmaceutical ready to launch Rifxima tablets in Japan
Read More
European Commission approves Trisenox for first-line treatment of low to intermediate risk APL
Read More
Boehringer Ingelheim launches idarucizumab as reversal agent for dabigatran in Japan
Read More
GSK submits NDA for closed triple combination therapy for COPD
Read More
Bristol-Myers Squibb launches elotuzumab in Japan
Read More
MSD K.K. launches elbasvir and grazoprevir in Japan
Read More
Bilanoa launched in Japan
Read More
Otsuka launches Iclusig in Japan
Read More
Laboratoris Sanifit reports clinical data on SNF-472
Read More